AnaptysBio (ANAB) earnings, May 12, 2026: EPS −116%, stock −3.4%
In brief
AnaptysBio reported on May 12, 2026. Earnings per share changed −116% year over year, 185.9% below the estimate; revenue −8%. The stock opened with a −0.9% gap and closed the day −3.4% (May 12, 2026). The stock is now 37.0% below its 52-week high, +89.9% over 12 months.
EPS vs estimate−185.9%
EPS, YoY−116%
Revenue, YoY−8%
Gap · day−0.9% · −3.4%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 6, 2025 | +4.5% | −9.6% |
| May 12, 2026 | −0.9% | −3.4% |
Next-quarter estimates, ratings and the ANAB chart are in the terminal.
Open the terminalFAQ
When is AnaptysBio's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did AnaptysBio stock react to the report?
Opening gap −0.9%, day's result −3.4%.
Did AnaptysBio's earnings grow?
Earnings per share fell 116% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.